| NCT Number | NCT06961019 |
| Lead Sponsor | NovoBliss Research Pvt Ltd |
| Conditions | Type2 Diabetes Mellitus |
| Enrollment | 14 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2026-03-14 (estimated) |
| Study Completion | 2026-03-14 (estimated) |
| Updated on ClinicalTrials.gov | 2026-08-06 |